Absent expression of FLNA is correlated with poor prognosis of nasopharyngeal cancer

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 2967-2974

  Sun, G G ^a   Lu, Y F ^b   Cheng, Y J ^c   Hu, W N ^a  

^a TANGSHAN PEOPLE S HOSPITAL   (China)

^b Tangshan Workers Hospital   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

FLNA; Immunohistochemical analysis; MMP 9; Nasopharyngeal carcinoma

Indexed keywords

FILAMIN A; GELATINASE B; LENTIVIRUS VECTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL MOVEMENT; FILAMINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 84898784762     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1381-z     Document Type: Article

References (21)

1. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004;5:423-8.
2. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in nasopharyngeal cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary nasopharyngeal carcinoma. Cancer Res. 2003;63:1454-7.
3. Zhou X, Boren J, Akyurek LM. Filamins in cardiovascular development. Trends Cardiovasc Med. 2007;17:222-9.
4. Ai J, Huang H, Lv X, Tang Z, Chen M, Chen T, et al. FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem. 2011;27:207-16.
5. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M, et al. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2001;2:138-45.
6. Sheen VL, Feng Y, Graham D, Takafuta T, Shapiro SS, Walsh CA. Filamin A and filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact. Hum Mol Genet. 2002;11:2845-54.
7. Feng Y, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol. 2004;6:1034-8.
8. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, et al. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res. 2009;15:788-96.
9. Bourguignon LY, Gilad E, Peyrollier K. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem. 2007;282:19426-41.
10. Nakamura F, Osborn TM, Hartemink CA, Hartwig JH, Stossel TP. Structure basis of filamin A functions. J Cell Biol. 2007;179:1011-25.
11. Roberson SP, Twigg SR, Sutherland-Smith AJ, Biancalana V, Gorlin RJ, Horn D, et al. Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diversem alform at ions in humans. Nat Genet. 2003;33:487-91.
12. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A, et al. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/ invasive phenotype. J Proteome Res. 2006;5:1143-54.
13. Shi JW, Yu YM, Wang SJ, Zhang J, Wang GY. Expressions of filamin A and matrix metalloproteinase 9 in colorectal adenocarcinoma and their significance. Tumor. 2010;30:768-73.
14. Wu YP, Li JB, Zhao RJ, Zhao RJ, Wang XL, Shan BE, et al. Expression of filamin A in invasive breast carcinoma and its significance. Tumor. 2009;29:659-62.
15. Watanabe H. Extracellular matrix-regulationof cancer invasion and metastasis. Gan ToKagaku Ryoho. 2010;37:2058-61.
16. Yu HB, Zhang HF, Li DY, Zhang X, Xue HZ, Zhao SH. Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res. 2011;13:242-50.
17. Zhang M, Zhu GY, Gao HY, Zhao SP, Xue Y. Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in nasopharyngeal adenocarcinoma. J Surg Oncol. 2011;103:243-7.
18. Yang S, Du J, Wang Z. BMP-6 promotes E-cadherin expressionthrough repressing delta EF1 in breast cancer cells. BMC Cancer. 2007;7:211.
19. Onoprishvili I, Ali S, Andria ML, Shpigel A, Simon EJ. Filamin A mutant lacking actin-binding domain restores mu opioid receptor regulation in melanoma cells. Neurochem Res. 2008;33:2054-61.
20. Zhu TN, He HJ, Kole S, D'Souza T, Agarwal R, Morin PJ, et al. Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells. J Biol Chem. 2007;282:14816-26.
21. He HJ, Kole S, Kwon YK, Crow MT, Bernier M. Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway. J Biol Chem. 2003;278:27096-104.